Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department
- PMID: 32048023
- DOI: 10.1007/s00431-020-03602-x
Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department
Abstract
Acute metabolic decompensation (AMD) of maple syrup urine disease (MSUD) must be promptly recognized and treated. In this study, we aimed to identify simple variables associated with AMD in children with MSUD for use in emergency settings. Data were collected retrospectively from 115 emergency visits of 29 children with MSUD over a 4-year period in a major referral hospital. Variables in visits with and without AMD were compared using t test, Mann-Whitney U test, and chi-square test. Logistic regression was used to identify independent variables associated with decompensations. Cut-off values of laboratory variables were determined with receiver operating characteristic curves and correlations with Spearman's rank correlation. Most important variables independently associated with AMD were poor feeding, malaise, anion gap, and especially uric acid, which correlated with leucine levels. Vomiting, dehydration, neurological signs, ketonuria, and ketoaciduria were also associated with AMD. Although sodium, chloride, and glucose were lower in AMD, they had little diagnostic value.Conclusion: In children with MSUD, uric acid and anion gap are key markers for AMD. Poor feeding and malaise are clues before the onset of neurological symptoms. These simple parameters can help determine the presence of AMD in emergency settings.What is Known:• In maple syrup urine disease, acute metabolic decompensations are characterized by gastrointestinal and neurological findings.• Diagnosis requires detection of significantly elevated leucine, which may take a long time or not be available.What is New:• Poor feeding, malaise, hyperuricemia, and high anion gap are parameters that can help diagnose acute decompensations in children with maple syrup urine disease at emergency departments.• Uric acid may be a biomarker for acute decompensations because of its high sensitivity, specificity, and its strong correlation with leucine.
Keywords: Acute metabolic decompensation; Anion gap; Maple syrup urine disease; Pediatric emergency; Uric acid.
Similar articles
-
Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study.Orphanet J Rare Dis. 2022 May 16;17(1):202. doi: 10.1186/s13023-022-02353-2. Orphanet J Rare Dis. 2022. PMID: 35578286 Free PMC article.
-
Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.J Inherit Metab Dis. 2017 Nov;40(6):783-792. doi: 10.1007/s10545-017-0083-x. Epub 2017 Sep 13. J Inherit Metab Dis. 2017. PMID: 28905140
-
Treatment of maple syrup urine disease with high flow hemodialysis in a neonate.Turk J Pediatr. 2019;61(1):107-110. doi: 10.24953/turkjped.2019.01.017. Turk J Pediatr. 2019. PMID: 31559730
-
Successful pregnancy in maple syrup urine disease: a case report and review of the literature.Nutr J. 2018 May 12;17(1):51. doi: 10.1186/s12937-018-0357-7. Nutr J. 2018. PMID: 29753318 Free PMC article. Review.
-
[Maple syrup urine disease of neonates: report of two cases and review of literature].Zhonghua Er Ke Za Zhi. 2010 Sep;48(9):680-4. Zhonghua Er Ke Za Zhi. 2010. PMID: 21092528 Review. Chinese.
Cited by
-
Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.Int J Mol Sci. 2020 Oct 11;21(20):7490. doi: 10.3390/ijms21207490. Int J Mol Sci. 2020. PMID: 33050626 Free PMC article. Review.
-
HMG-CoA Synthase-2 Deficiency: Neonatal Hyperammonemic Coma and Abnormal Metabolic Screening Resembling Maple Syrup Urine Disease.JIMD Rep. 2025 Jun 22;66(4):e70028. doi: 10.1002/jmd2.70028. eCollection 2025 Jul. JIMD Rep. 2025. PMID: 40548098 Free PMC article.
-
Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study.Orphanet J Rare Dis. 2022 May 16;17(1):202. doi: 10.1186/s13023-022-02353-2. Orphanet J Rare Dis. 2022. PMID: 35578286 Free PMC article.
References
-
- Strauss KA, Puffenberger EG, Morton DH (2013) Maple syrup urine disease. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE (eds) GeneReviews. https://www.ncbi.nlm.nih.gov/books/NBK1319 . Accessed 2 June 2019
-
- Carleton SM, Peck DS, Grasela J, Dietiker KL, Phillips CL (2010) DNA carrier testing and newborn screening for maple syrup urine disease in Old Order Mennonite communities. Genet Test Mol Biomarkers 14:205–208. https://doi.org/10.1089/gtmb.2009.0107 - DOI - PubMed - PMC
-
- Dursun A, Henneke M, Ozgul K, Gartner J, Coşkun T, Tokatli A, Kalkanoglu HS, Demirkol M, Wendel U, Ozalp I (2002) Maple syrup urine disease: mutation analysis in Turkish patients. J Inherit Metab Dis 25:89–97 - DOI
-
- Blackburn PR, Gass JM, Vairo FPE, Farnham KM, Atwal HK, Macklin S, Klee EW, Atwal PS (2017) Maple syrup urine disease: mechanisms and management. Appl Clin Genet 10:57–66. https://doi.org/10.2147/TACG.S125962 - DOI - PubMed - PMC
-
- Rodan LH, Aldubayan SH, Berry GT, Levy HL (2018) Acute illness protocol for maple syrup urine disease. Pediatr Emerg Care 34:64–67. https://doi.org/10.1097/PEC.0000000000001299 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous